Picture of Benitec Biopharma logo

BNTC Benitec Biopharma Balance Sheet

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapMomentum Trap

Annual balance sheet for Benitec Biopharma, fiscal year end - June 30th, USD millions except per share, conversion factor applied.

2019
June 30th
2020
June 30th
2021
June 30th
2022
June 30th
2023
June 30th
Period Length:
Source:ARS10-K10-K10-K10-K
Standards:
IFRS
USG
USG
USG
USG
Status:
fx
Final
FinalFinalFinalFinal
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments15.99.819.84.062.48
Net Total Accounts Receivable
Net Total Receivables2.540.0590.0250.0030.055
Prepaid Expenses
Total Other Current Assets
Total Current Assets18.810.820.64.823.73
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment0.470.7690.5770.9930.613
Long Term Investments
Other Long Term Assets
Total Assets19.311.621.45.974.46
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities2.641.141.372.533.98
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities2.641.351.373.094.26
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity16.610.2202.880.202
Total Liabilities & Shareholders' Equity19.311.621.45.974.46
Total Common Shares Outstanding